Browsing "Pathology" by Author Ahern, M.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
PreviewIssue DateTitleAuthor(s)
1997Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid, and synovial membrane in rheumatoid arthritisYoussef, P.; Haynes, D.; Triantafillou, S.; Parker, A.; Gamble, J.; Roberts-Thomson, P.; Ahern, M.; Smith, M.
2009Elevated expression of caspase-3 inhibitors, survivin and xIAP correlates with low levels of apoptosis in active rheumatoid synoviumDharmapatni, A.; Smith, M.; Findlay, D.; Holding, C.; Evdokiou, A.; Ahern, M.; Weedon, H.; Chen, P.; Screaton, G.; Xu, X.; Haynes, D.
2005Histopathological and ultrastructural features of dermal telangiectasias in systemic sclerosisWalker, J.; Stirling, J.; Beroukas, D.; Dharmapatni, A.; Haynes, D.; Smith, M.; Ahern, M.; Roberts-Thomson, P.
2008Modulation of RANKL and osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis in response to disease-modifying antirheumatic drug treatment and correlation with radiologic outcomeHaynes, D.; Crotti, T.; Weedon, H.; Slavotinek, J.; Au, V.; Coleman, M.; Roberts-Thomson, P.; Ahern, M.; Smith, M.
2003Receptor activator NF kB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitisCrotti, T.; Smith, M.; Hirsch, R.; Soukoulis, S.; Weedon, H.; Capone, M.; Ahern, M.; Haynes, D.
2002Receptor activator NFκB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysisCrotti, T.; Smith, M.; Weedon, H.; Ahern, M.; Findlay, D.; Kraan, M.; Tak, P.; Haynes, D.
2003Variability of RANKL and osteoprotegerin staining in synovial tissue from patients with active rheumatoid arthritis: Quantification using color video image analysisCrotti, T.; Ahern, M.; Lange, K.; Weedon, H.; Coleman, M.; Roberts-Thomson, P.; Haynes, D.; Smith, M.